Portuguese consensus for the use of cladribine tablets in multiple sclerosis

Key Points

• To establish guidelines for the use of cladribine tablets in treating relapsing remitting multiple sclerosis (RRMS).
• Reviewed clinical trials on cladribine tablets
• Analyzed real-world studies for efficacy and safety
• Consolidated expert consensus on treatment practices
• Cladribine tablets showed significant efficacy in reducing relapses in RRMS.
• Safety profile aligns with other disease-modifying therapies.
• Guidelines aim to standardize treatment decisions among clinicians.